BioCleanT Nitrile Clean RABS/Isolator Gloves, Port size: 203 (C08-0203-793)

Thomas Scientific

Catalog No.: C08-0203-793
Manufacturer No.: CGL20NIT59
Manufacturer Name: ANSELL
Quantity: 1
Unit of Measure: EA

Price: $323.47

List Price: $359.41

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account.

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Non-sterile RABS/Isolator Gloves Specialized protection: Suitable for handling chemotherapy drugs, these nitrile isolator/RABS gloves are also resistant to vaporized hydrogen peroxide (VHP), isopropyl alcohol (IPA) and common disinfectants Enhanced safety: 100% water leak tested, these nitrile isolator/RABS gloves ensure dependable wearer and product protection against liquids Optimized cleanliness: They are processed in accordance with ISO cleanroom standards, for ultra-clean RABS gloves with low levels of particles Key Features and Benefits ASTM D6978-05 compliance: Ability to handle chemotherapy drugs 100% water leak tested: Truly reliable personal protection ISO cleanroom processed: For ultra-clean isolator gloves

UPC:: 41100000
Condition:: New
Availability:: 3 Days
Weight:: 1.00 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: CGL20NIT59

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."